Chitnis, Amit S.
Cheung, Ramsey
Gish, Robert G.
Wong, Robert J.
Article History
Accepted: 12 June 2021
First Online: 23 June 2021
Declarations
:
: Amit S. Chitnis, Ramsey Cheung declares that they have no conflict of interest. Robert G. Gish—consulting, advisor—Abbot, AbbVie, Alexion, Arrowhead, Bayer AG, Biocollections, Bristol-Myers Squibb Company, Eiger, Enyo, eStudySite, Genentech, Gilead Sciences, HepaTX, HepQuant, Hoffmann-LaRoche Ltd., Intellia, Intercept, Ionis Pharmaceuticals, Janssen, MedImmune, Merck, Prometheus, Quest, Shionogi, Transgene, Trimaran. Scientific/clinical advisory boards—AbbVie, Merck, Arrowhead, Bayer, Dova Pharmaceuticals, Eiger, Enyo, Janssen, Medimmune, Janssen/J&J, Intercept, Shionogi, Spring Bank. Clinical trials—eStudySite. Chair clinical advisory board—Arrowhead. Data safety monitoring board—Ionis. Speaker’s bureau – AbbVie, Alexion, Bayer, BMS, Gilead Sciences Inc., Merck. Robert J. Wong—recipient of research grants to his academic institution from Gilead Sciences, and has served as a consultant on the advisory board and speaker’s bureau for Gilead Sciences.